Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.arbres.2016.07.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Treatment of intractable bronchopleural fistula with a one-side-closed silicone stent using retrograde approach: A case report.
Respir Med Case Rep
October 2024
Department of Thoracic Surgery, Kochi Medical University, Kochi, Japan.
A male patient (age: 85 -years) with lung cancer underwent basal segmentectomy. Subsequently, he underwent emergency open window thoracotomy for a bronchial stump fistula. The general and nutritional conditions of the patient improved; nevertheless, natural closure of the fistula did not occur.
View Article and Find Full Text PDFNavigating complexity and sealing the threat: Ultrasound and CT guided percutaneous glue embolization of bronchial artery pseudoaneurysm with challenging anatomy.
Radiol Case Rep
January 2025
Department of Radiology SKG, SJOG Murdoch, 100 Murdoch Drive, Perth, WA 6150, Australia.
Bronchial artery aneurysms are a rare vascular pathology, however bronchial artery pseudoaneurysms are even less commonly observed with minimal cases available in the literature. They are often associated with conditions such as lung infections or malignancies and are typically managed with endovascular embolization. However, complex vascular anatomy may render endovascular approaches unsuitable.
View Article and Find Full Text PDFThe efficacy, safety, and related factors of bronchial artery embolization for hemoptysis: a systematic review and meta-analysis with subgroup analysis.
Cardiovasc Diagn Ther
October 2024
Department of Radiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Background: Bronchial artery embolization (BAE) is a common and important way to manage hemoptysis. This study's purpose was to summarize the efficacy, safety, and related factors of BAE in the treatment of hemoptysis.
Methods: From January 2010 to August 2023, a systematic literature search was conducted in PubMed, EMBASE, Web of Science, and Cochrane Library databases.
Successful embolization of a primary bronchial artery racemose hemangioma by the ingenious use of a microballoon catheter.
Radiol Case Rep
October 2024
Department of Radiology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan.
Article Synopsis
- Primary racemose hemangioma of the bronchial artery (RHBA) is a rare congenital condition involving enlarged bronchial arteries that may form abnormal connections with other blood vessels.
- A case study reports successful balloon-assisted embolization for a 57-year-old asymptomatic woman with RHBA, utilizing a specialized catheter system to precisely deliver a treatment mixture to the affected areas.
- This method is preferred to prevent the risk of artery rupture caused by the dilated vessels, effectively guiding treatment while controlling blood flow.
[Retrospective Study of Bronchoscopic Intervention Therapy for Bronchopleural Fistula Induced by Pulmonary Surgery].
Zhongguo Fei Ai Za Zhi
March 2024
Respiratory Disease Center, Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing 101121, China.
Background: As a new technique developed in recent years, bronchoscopic intervention therapy has the advantages of minimal invasion, high safety and repeatability. The aim of this study is to investigate the clinical characteristics of bronchopleural fistula (BPF) induced by surgeries for lung malignancies or benign diseases and the effect of bronchoscopic intervention therapy for BPF, so as to provide support for prevention and treatment of BPF.
Methods: Data 64 patients with BPF who were treated by bronchoscopic intervention in Respiratory Disease Center of Dongzhimen Hospital, Beijing University of Chinese Medicine from June 2020 to September 2023 were collected.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!